VRCI vs. YGEN, ABDX, PRM, GDR, GENI, DMTR, LLAI, LLA, IDHC, and DXRX
Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), genedrive (GDR), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), and Diaceutics (DXRX). These companies are all part of the "diagnostics & research" industry.
Verici Dx vs.
Yourgene Health (LON:YGEN) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.
In the previous week, Yourgene Health's average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.
Verici Dx has lower revenue, but higher earnings than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.
Yourgene Health received 17 more outperform votes than Verici Dx when rated by MarketBeat users.
Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.
Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500.
23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 51.9% of Verici Dx shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by insiders. Comparatively, 17.1% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Yourgene Health beats Verici Dx on 7 of the 11 factors compared between the two stocks.
Get Verici Dx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Verici Dx Competitors List
Related Companies and Tools
This page (LON:VRCI) was last updated on 3/28/2025 by MarketBeat.com Staff
